Prognostic Factors Influencing Survival in Ovarian Cancer Patients: A 10-Year Retrospective Study

Author:

Andreou Maria1,Kyprianidou Maria1,Cortas Christos2ORCID,Polycarpou Irene1ORCID,Papamichael Demetris2,Kountourakis Panteleimon23ORCID,Giannakou Konstantinos1ORCID

Affiliation:

1. Department of Health Sciences, School of Sciences, European University Cyprus, Nicosia 1516, Cyprus

2. Department of Medical Oncology, Bank of Cyprus Oncology Centre, Nicosia 2006, Cyprus

3. Department of Medical Oncology, Mediterranean Hospital of Cyprus, Limassol 3117, Cyprus

Abstract

Objective: To analyze the factors associated with overall survival (OS) and progression-free survival (PFS) in patients with ovarian cancer in Cyprus. Methods: We retrospectively analyzed data from patients with histologically confirmed epithelial ovarian cancer (EOC) and primary peritoneal cancer (PPC). Results: A total of 106 women diagnosed with ovarian cancer were included, with a median age at diagnosis of 58 years. The Kaplan–Meier survival analysis showed a median OS of 41 months (95% C.I = 36.9, 45.1), and the FIGO stage (p < 0.001), type of surgery (p < 0.001) and performance status (p < 0.001) were identified as statistically significant prognostic factors for OS. PFS analysis revealed the FIGO stage (p = 0.006) and the performance status (p < 0.001) as significant prognostic factors. Additionally, a Cox regression analysis for median OS was performed for patients with high-grade serous carcinoma, identifying the performance status, FIGO stage, and type of surgery as prognostic factors in univariate analysis. However, in the subsequent multivariate analysis, the performance status and the FIGO stage were confirmed to be the only statistically significant prognostic factors for OS (p < 0.05). Conclusions: This study confirms that the FIGO stage, performance status, and surgery type were considered as prognostic factors for OS in ovarian cancer.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference55 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Cancer statistics, 2021;Siegel;CA Cancer J. Clin.,2021

3. NCCN guidelines insights: Ovarian cancer, version 1.2019: Featured updates to the NCCN guidelines;Armstrong;J. Natl. Compr. Cancer Netw.,2019

4. Primary peritoneal cancer: Study of 14 cases and comparison with epithelial ovarian cancer;Fukuda;Eur. J. Gynaecol. Oncol.,2015

5. Ovarian cancer;Eur. J. Cancer Prev.,2017

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3